Open Access

Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS‑induced BV2 cells in vitro and in vivo

  • Authors:
    • Miaoxuan Sun
    • Yi Sheng
    • Yanyan Zhu
  • View Affiliations

  • Published online on: April 2, 2021     https://doi.org/10.3892/etm.2021.10018
  • Article Number: 586
  • Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ginkgolide B (GB) is widely used in the treatment of neurological diseases and exerts anti‑inflammatory and neuroprotective effects. Microglia serve an important role in central nervous inflammation. The present study investigated the effect of GB on central nervous inflammation in vivo and in vitro. BV2 cells were activated with lipopolysaccharide (LPS) to establish a cellular model of neuroinflammation. Cell viability was determined using the Cell Counting Kit‑8 assay and the secreted levels of TNF‑α, IL‑1 and IL‑6 were measured using ELISAs. The levels of nitric oxide (NO) was assessed using Griess assays. In addition, the mRNA and protein expression levels of inducible NO synthase and cyclooxygenase‑2 (COX‑2) were detected using reverse transcription‑quantitative PCR and western blot analyses, respectively. Transwell assays were carried out to evaluate the cell migratory ability. For the in vivo studies, an LPS‑induced neuroinflammation model was established in C57 mice. Western blot analysis and immunohistochemistry were performed to detect the expression of the microglial marker allograft inflammatory factor 1 in the hippocampal dentate gyrus and striatum. The expression levels of TNF‑α, IL‑1 and IL‑6 in the hippocampal dentate gyrus and striatum were assessed using western blot analysis. The results revealed that GB reduced the inflammatory response and migration of LPS‑induced BV2 cells. Furthermore, GB attenuated the activation of BV2 cells of the hippocampal dentate gyrus and striatum in the LPS‑induced mice with neuroinflammation. Taken together, the findings of the present study demonstrated that GB alleviated the inflammatory response and attenuated the activation of LPS‑induced BV2 cells in vitro and in vivo.
View Figures
View References

Related Articles

Journal Cover

June-2021
Volume 21 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun M, Sheng Y and Zhu Y: Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS‑induced BV2 cells <em>in vitro</em> and <em>in vivo</em>. Exp Ther Med 21: 586, 2021
APA
Sun, M., Sheng, Y., & Zhu, Y. (2021). Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS‑induced BV2 cells <em>in vitro</em> and <em>in vivo</em>. Experimental and Therapeutic Medicine, 21, 586. https://doi.org/10.3892/etm.2021.10018
MLA
Sun, M., Sheng, Y., Zhu, Y."Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS‑induced BV2 cells <em>in vitro</em> and <em>in vivo</em>". Experimental and Therapeutic Medicine 21.6 (2021): 586.
Chicago
Sun, M., Sheng, Y., Zhu, Y."Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS‑induced BV2 cells <em>in vitro</em> and <em>in vivo</em>". Experimental and Therapeutic Medicine 21, no. 6 (2021): 586. https://doi.org/10.3892/etm.2021.10018